Purpose
Preoperative chemoradiotherapy (CRT) is part of the standard treatment of locally advanced rectal cancers. Tumour regression at the time of operation is desirable, but not much is known about the relationship between radiation dose and tumour regression. In the present study we estimated radiation dose-response curves for various grades of tumour regression after preoperative CRT.
Methods and Materials
A total of 222 patients, treated with consistent chemotherapy and radiotherapy techniques, were considered for the analysis. Radiotherapy consisted of a combination of external beam radiotherapy and brachytherapy. Response at the time of operation was evaluated from the histopathological specimen and graded on a five point scale (TRG1-5). The probability of achieving complete, major and partial response was analyzed using ordinal logistic regression, and the effect of including clinical parameters in the model was examined. The radiation dose response relationship for a specific grade of histopathological tumour regression was parameterized in terms of the dose required for 50% response, D50,i, and the normalized dose-response gradient, γ50,i.
Results
A highly significant dose–response relationship was found (p=0.002). For complete response (TRG1) the dose-response parameters were D50,TRG1=92.0 Gy (95% CI: 79.3 to 144.9 Gy), γ50,TRG1=0.982 (0.533 to 1.429), and for major response (TRG1-2) D50,TRG1&2=72.1 Gy (65.3 to 94.0 Gy), γ50,TRG1&2=0.770 (0.338 to 1.201). Tumour size and N-category both had a significant effect on the dose-response relationships.
Conclusions
This study has demonstrated a significant dose-response relationship for tumour regression after preoperative CRT for locally advanced rectal cancer for tumour dose levels in the range of 50.4 to 70 Gy, which is higher than the dose-range usually considered.
Neoadjuvant chemotherapy in colon cancer is feasible and the results suggest that a major part of the patients can be spared adjuvant chemotherapy. Validation in a randomized trial is warranted.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.